Viewing Study NCT00616902


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-02-06 @ 6:31 AM
Study NCT ID: NCT00616902
Status: TERMINATED
Last Update Posted: 2012-01-20
First Post: 2008-02-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Sponsor: Abbott
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease (CKD) Stage 5 View
None Hypertrophy, Left Ventricular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Zemplar, paricalcitol, PRIMO II View